Digoxin therapy and survival in heart failure in sinus rhythm

Area of Science:

• Cardiology
• Pharmacology
• Clinical Research

Background:

• Heart failure is a major cause of morbidity and mortality.
• Digoxin is a medication historically used to manage heart failure symptoms.
• The safety of digoxin in patients with heart failure and sinus rhythm requires ongoing evaluation.

Purpose of the Study:

• To assess the effect of digoxin therapy on the survival rates of heart failure patients in sinus rhythm.
• To investigate the safety profile of digoxin in managing acute exacerbations of chronic heart failure.
• To determine the risk of mortality associated with digoxin use in this specific patient population.

Main Methods:

• A retrospective case-control study design was employed.
• Patients with acute exacerbation of chronic heart failure due to ischemic heart disease in sinus rhythm, treated with digoxin, were selected.
• Case-matched controls were identified for each digoxin-treated patient.

Main Results:

• A significantly increased relative risk of death (6.4) was observed for digoxin-treated patients during hospitalization.
• This elevated risk of death persisted for up to one year following hospital discharge.
• The study population comprised 18 digoxin-treated patients and 18 matched controls.

Conclusions:

• Digoxin therapy in heart failure patients with sinus rhythm is associated with increased mortality.
• The findings raise concerns about the safety of using digoxin for heart failure exacerbations in patients maintaining sinus rhythm.
• Further research is warranted to explore alternative treatments and understand the mechanisms behind digoxin's potential adverse effects.